AzTrials
AzTrials

Mechanical Ventilation ComplicationNCT04423614

Preoperative Inspiratory Muscle Training

A study testing Inspiratory Muscle Training and Relaxation Breathing in people with Mechanical Ventilation Complication, run by University of Florida.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

In light of the corona virus pandemic (COVID-19), there is critical need to conserve scarce mechanical ventilation (MV) resources. This study evaluates an intervention in non-infected cardiac patients as a means to assist with minimizing MV and ICU length of stay (LOS). Read more about this study

Who is it for?
Ages 55 to 80 years
Conditions the study is for
Mechanical Ventilation Complication
What is being tested?
Inspiratory Muscle Training and Relaxation Breathing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
Dec 2021to 5 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Cardiac surgery candidate
  • Ability to complete pre-operative breathing exercises

Who cannot join

  • Surgery is scheduled in less than 2 weeks
  • New York Heart Association Class III or IV Cardiac Disease
  • History of hemiparesis
  • History of spinal cord injury
  • History of progressive neuromuscular disease that may interfere with the ability to complete study interventions
  • Previous cardiothoracic surgery within the last 12 weeks
Show all 13Show fewer
  • History of pneumonectomy
  • History of lung surgery
  • History of skeletal pathology (e.g. scoliosis) that may interfere with chest wall movements
  • Routine usage of muscle relaxants, immunosuppressants, or corticosteroid medications within the past 30 days
  • Forced expiratory volume 1 less than 40% of age-predicted value
  • Presence of active malignancy
  • Presence of any organ dysfunction that may limit ability to participate in seated respiratory exercises

About this study

Official title: Telehealth-Delivered Preoperative Inspiratory Muscle Training: An Innovative Solution to Conserve Scarce ICU Resources

In light of the corona virus pandemic (COVID-19), there is critical need to conserve scarce mechanical ventilation (MV) resources. This study evaluates an intervention in non-infected cardiac patients as a means to assist with minimizing MV and ICU length of stay (LOS). Pre-op inspiratory muscle training (IMT) has been shown to decrease pulmonary complications, MV dependence, and ICU LOS following thoracic surgery. The investigators aim to determine the mechanism of remodeling in diaphragms of adults who undergo pre-op IMT.

Read the detailed description

Highly active muscles such as the diaphragm are particularly sensitive to both disuse and training. For example, diaphragm fibers of controlled mechanically ventilated young adults atrophy by more than 50% within 36 hours of complete inactivity, and mechanical ventilation (MV) initiates signaling pathways within the first several hours of inactivity that promote progressive diaphragmatic fiber dysfunction. The investigators have shown that widespread atrophy signaling begins in the operating room during cardiac surgery, after only a few hours of MV. In addition to this fiber atrophy, MV leads to significant declines in the strength of the diaphragm, which can lengthen the time it takes to wean from MV. The clinical occurrence of early onset, progressive contractile dysfunction is defined as ventilator-induced diaphragmatic dysfunction (VIDD). VIDD is regarded as a primary contributor to difficulties with weaning from MV.

Conversely, the investigators have shown that IMT increases the pressure-generating capacity of the diaphragm and inspiratory synergist muscles, and facilitates weaning in patients with VIDD. Preoperative IMT for as little as 1-2 weeks reportedly increases inspiratory muscle strength. IMT prior to cardiothoracic surgery has been shown to reduce post-operative pulmonary complications such as atelectasis, pneumonia, or delayed ventilator weaning. Additionally, strength gains associated with preoperative IMT are associated with shorter ICU and hospital lengths of stay, which may potentially offer a cost benefit.

Unfortunately, very little is understood about the neuromuscular adaptations and signaling mechanisms that contribute to these IMT clinical advantages. A particularly novel aspect of this project is it will be the first study of the mechanisms that contribute to diaphragm strengthening. A greater understanding of these mechanisms may help future investigators to develop more efficient exercise prescriptions to offset MV use in cases such as surgery, and it may help identify molecules and exercise that could protect the diaphragms of individuals who cannot exercise in advance, as in the case of acute infections that compromise breathing.

The overall objective of this study is to investigate diaphragm neuromuscular remodeling associated with pre-operative, telehealth delivered IMT, compared with relaxation breathing training (RLX). Guided RLX exercises have been shown to improve post-operative pain perception and modestly lower systolic blood pressure in hypertensives but are not thought to significantly alter diaphragm strength.

Forty adult volunteers will receive either IMT (n=20) or RLX training (n=20) for 2-4 weeks prior to elective cardiothoracic surgery and undergo breathing performance tests before and after the training period. A full thickness biopsy (approximately 6mm x 20 mm) from the right ventral costal diaphragm will be acquired as soon as the diaphragm is exposed during surgery. Additionally, a biopsy from the pectoralis major will be obtained and used as a non-exercised control muscle. Histological and RNA sequencing analyses will be performed to examine the mechanisms that contribute to neuromuscular adaptations to training.

Being tested
Inspiratory Muscle Training, Relaxation Breathing
Keywords
Mechanical ventilation, Inspiratory muscle training, Difficulty weaning from mechanical ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inspiratory Muscle TrainingOther

    Inspiratory muscle training exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.

  • Relaxation BreathingOther

    Relaxation breathing exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.

Study groups in NCT04423614
Study groupRoleWhat they receive
Inspiratory Muscle Training (IMT)ExperimentalPre-operative inspiratory muscle training
Receives: Other: Inspiratory Muscle Training
Relaxation Breathing (RLX)ExperimentalRelaxation breathing exercises
Receives: Other: Relaxation Breathing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal inspiratory pressure

    Maximal inspiratory pressure will be quantified in cm of water pressure.

    Measured: Post breathing exercise sessions (up to 4 weeks)

  2. Muscle fiber cross-sectional area and fiber type proportion.

    Histology will be used to determine fiber type and cross-sectional area using primary antibodies for laminin and type-specific myosin heavy chain, followed by a triple immunofluorescence-conjugated secondary antibody labeling technique.

    Measured: Intra-operatively

Secondary outcomes (8)
  1. Peak expiratory flow

    Spirometry will be used to measure peak expiratory flow during a voluntary cough maneuver. It will be quantified in liters per second.

    Measured: Post breathing exercise sessions (up to 4 weeks)

  2. Time to extubation

    Time to extubation will be measured as hours of post-operative mechanical ventilation.

    Measured: Up to discharge from ICU

  3. Length of ICU stay

    Length of ICU stay will be measured as hours spent in ICU after surgery.

    Measured: Up to 1 month

  4. Length of hospital stay

    Length of hospital stay will be measured as hours spent in hospital after surgery.

    Measured: Up to 1 month

  5. Neuromuscular junction morphology

    Histology will be used to assess neuromuscular junction number and morphology using immunofluorescent-labeled antibodies for synaptophysin and alpha bungarotoxin. Neuromuscular junction image stacks will be visualized with confocal microscopy and morphology classified according to endplate area and area fractions of fragmented junctions, acetylcholine receptor-occupied endplate area, synaptophysin-occupied endplates, and abandoned endplates.

    Measured: Intra-operatively

  6. Muscle differential gene expression

    RNA isolation will be performed using Tri Reagent and chloroform based manual method. RNA will be quantified and RNA-Seq will be used to assess gene expression.

    Measured: Intra-operatively

  7. Physical Function

    Physical function will be assessed with the Patient Reported Outcomes Measurement Information System Physical Function questionnaire. Each answer corresponds to a number between 1 and 5.

    Measured: Post breathing exercise sessions (up to 4 weeks)

  8. Dyspnoea

    Dyspnoea will be assessed with the Dyspnoea 12 Questionnaire. Responses range from None to Severe.

    Measured: Post breathing exercise sessions (up to 4 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2020
  2. Study startDec 2021 (estimated)
  3. Primary completion5 Jan 2022
  4. Study completion5 Jan 2022

Why it stopped: Study staff were busy with other projects and unable to devote time to this study

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects will be randomized into one of two arms. In Arm 1, subjects will perform pre-operative inspiratory muscle training. In Arm 2, subjects will perform pre-operative relaxation breathing. A diaphragm biopsy will be taken during surgery for both arms and the tissue will be compared. In addition, a biopsy of the pectoralis major will be obtained from each subject and serve as a non-exercised control which will compared to the subject's diaphragm muscle biopsy (which participated in the intervention).
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04423614
Sponsor's protocol ID
IRB202001038
Other IDs
OCR35362
Status last verified
Jan 2022
First submitted
2 Jun 2020
Last updated
21 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Inspiratory Muscle Training and Relaxation Breathing in people with Mechanical Ventilation Complication, run by University of Florida.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 21 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal inspiratory pressure (time frame: Post breathing exercise sessions (up to 4 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in